Advanced search
Publication Cover
International Journal of Hyperthermia Volume 19, 2003 - Issue 4
Submit an article Journal homepage
141
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Induction of apoptosis by carboplatin and hyperthermia alone or combined in WERI human retinoblastoma cells

E. K. Choi University of Ulsan College of Medicine, Department of Radiation Oncology, 388-1 Pungnap-Dong, Songpa-Gu, Seoul 138-736, Korea
,
S. R. Park Inha University College of Medicine, Department of Microbiology, Jungsuck B/D B-Dong 3F, 7-241, 3rd St., Shinheung-Dong, Choong-Gu, Inchon, 400-103, Korea
,
J.-H. Lee Catholic University, College of Medicine, Department of Biochemistry, 505 Banpo-Dong, Seocho-Gu, Seoul 138-736, Korea
,
H. S. Chung Inha University College of Medicine, Department of Microbiology, Jungsuck B/D B-Dong 3F, 7-241, 3rd St., Shinheung-Dong, Choong-Gu, Inchon, 400-103, Korea
,
H. E. Ahn Inha University College of Medicine, Department of Microbiology, Jungsuck B/D B-Dong 3F, 7-241, 3rd St., Shinheung-Dong, Choong-Gu, Inchon, 400-103, Korea
,
Y. H. Rhee University of Ulsan College of Medicine, Department of Radiation Oncology, 388-1 Pungnap-Dong, Songpa-Gu, Seoul 138-736, Korea
,
B. U. Lim Inha University College of Medicine, Department of Microbiology, Jungsuck B/D B-Dong 3F, 7-241, 3rd St., Shinheung-Dong, Choong-Gu, Inchon, 400-103, Korea
&
H. J. Park Inha University College of Medicine, Department of Microbiology, Jungsuck B/D B-Dong 3F, 7-241, 3rd St., Shinheung-Dong, Choong-Gu, Inchon, 400-103, Korea
 show all
Pages 431-443 | Published online: 09 Jul 2009

  • Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994; 28: 163-9.
  • Overgaard J, Gonzalez DG, Hume SP, Arcangeli G, Dahl O, Mella O, Bentzen SM. C hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995; 345: 540-3.
  • Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WLJ, van Dijk GC, Gonzalez JDP, Sheran M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 1996; 35: 731-44.
  • van der Zee J, Gonzalez GD, van Rhoon GC, van Dijk JD, van Putten WL, Hert AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomized, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119-25.
  • Harrima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage HIB cervical carcinoma. Int J Hyperthermia 2001; 17: 97-105.
  • Kusumoto T, Holden SA, Ara G, Teicher BA. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo. Int J Hyperthermia 1995; 11: 575-86.
  • Greenwald MJ, Strauss LC. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Opthalmology 1996; 103: 1989-97.
  • Muphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1348-56.
  • Raaphorst GP, Doja S, Davis L, Stewart D, Ng CE. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell Unes sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacol 1996; 37: 574-80.
  • van Bree C, Rietbroek RC, Schopman EM, Kipp JB, Bakker PJ. Local hyperthermia enhances the effect of cisdiamminedichloro-platinum(11) on nonirradiated and preirradiated rat solid tumors. Int J Radiat Oncol Biol Phys 1996; 36: 135-40.
  • Beketic-Oreskovic L, Jaksic M, Oreskovic S, Osmak M. Hyperthermic modulation of resistance to cisdiamminedichloroplatinum (11) in human larynx carcinoma cells. Int J Hyperthermia 1997; 13: 205-14.
  • Hettinga JV, Lemstra W, Meijer C, Dam WA, Uges DR, Konings AW, De Vries EG, Kampinga HH. Mechanism of hyperthermia potentiation of cisplatin action in cisplatinsensitive and -resistant tumour cells. Br J Cancer 1997; 75: 1735-43.
  • Murray TG, Cicciarelli N, McCabe CM, Ksander B, Feuer W, Schiffman J, Mieler WF, O'Brien JM. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line. Invest Opthalmol Vis Sd 1997; 38: 2516-22.
  • Ohtsubo T, Saito H, Tanaka N, Tsuzuki H, Saito T, Kano E. In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharyngeal carcinoma KB cells. Chemotherapy 1997; 43: 43-50.
  • Rietbroek RC, Schilthuis MS, Baker PJ, van Dijk JD, Postma AJ, Gonzalez Gonzalez D, Bakker AJ, van der Velden J, Heimerhorst TJ, Veenhof CH. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 1997; 79: 935-43.
  • Di Felice V, Lauricella M, Giuliano M, Emanuele S, Vento R, Tesoriere G. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. Int J Oncol 1998; 13:22532.
  • Levy C, Doz F, Quintana E, Pacquement H, Michon J, Schlienger P, Validire P, Asselain B, Desjardins L, Zucker JM. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results. Br J Opthalmol 1998; 82: 1154-8.
  • Masuda H, Tanaka T, Matsushima S. Hyperthermic enhancement of cisplatin-induced generation of active oxygen radicals in a cell-free system. Anticancer Res 1998; 18:1473-7.
  • de Wit R, van der Zee J, van der Burg ME, Kruit WH, Logmans A, van Rhoon GC, Verweij J. A phase 1/11 study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer 1999; 80: 1387-91.
  • Reynolds T. Advances in treatment for eye cancer bring visible benefits. J Natl Cancer Inst 1999; 91; 1804-5.
  • Serin M, Erkal HS, Cakmak A. Radiation therapy, cisplatin and hyperthermia in combination in management of patients with carcinomas of the head and neck with N2 or N3 metastatic cervical lymph nodes. Radiother Oncol 1999; 50: 103-6.
  • Shields CL, Santos MC, Diniz W, Gunduz K, Mercado G, Cater JR, Shields JA. Thermotherapy for retinoblastoma. Arch Opthalmol 1999; 117: 885-93.
  • Hermission M, Weller M. Hyperthermia enhanced chemosensitivity of human malignant glioma cells. Anticancer Res 2000; 20: 1819-23.
  • Lauricella M, Giuliano M, Emanuele S, Vento R, Tesoriere G. Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells. Tumour Biol 1998; 19: 356-63.
  • Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999; 15: 79-107.
  • Kaste SC, Chen G, Fontanesi J, Crom DB, Pratt CB. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol 1997; 15: 1183-9.
  • Kingston JE, Hungerford JL, Madreperla SA, Plowman PN. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1339-43.
  • Shields CL, DePotter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Opthalmol 1996; 114: 1330-8.
  • Lagendijk JJ. A microwave heating technique for the hypothermie treatment of tumours in the eye, especially retinoblastoma. Phys Med Biol 1982; 27: 1313-24.
  • Riedel KG. Hyperthermic therapy procedures for supplementing radiotherapy of malignant intraocular tumors. Klin Monatsbl Augenheilkd 1988; 193: 131-7.
  • Inomata M, Kaneko A, Kunimoto T, Saijo N. In vitro thermo- and thermochemosensitivity of retinoblastoma cells from surgical specimens. Int J Hyperthermia 2002; 18: 50-61.
  • Eastman A. Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(11) and cis-dichloro (ethilenediammine) platinum (II). Biochemistry 1983; 22: 3927-33.
  • Calvert H, Judson I, van der Vijgh WJF. Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity (Review). Cancer Surv 1993; 17: 189-217.
  • Conway RM, Madigan MC, Billson FA, Penfold PL. Vincristine- and cisplatin-induced apoptosis in human retinoblastoma. Potentiation by sodium butyrate. Eur J Cancer 1998; 34: 1741-8.
  • Takasu T, Lyons JC, Park HJ, Song CW. Apoptosis and perturbation of cell cycle progression in an acidic environment following hyperthermia. Cancer Res 1998; 58: 2504-8.
  • Ohtsubo T, Park HJ, Lyons JC, Ohnishi T, Song CW. Effect of acidic environment and p53 on apoptosis induction by hyperthermia. Int J Hyperthermia 2000; 16: 481-91.
  • Ohtsubo T, Igawa H, Saito T, Matsumoto H, Park H, Song CW, Kano E, Saito H. Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42 degrees C and cisplatin. Radiat Res 2001; 156: 103-9.
  • Lee J-H, Takahashi T, Yasuhara N, Inazawa J, Kamada S, Tsujimoto Y. Bis, a Bcl-2binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 1999; 18: 6183-90.
  • Chae Y-J, Kim HS, Rhim HS, Kim B-E, Jeong S-W, Kim I-K. Activation of caspase-8 in 3-deazaadenosine-induced apoptosis of U-937 cell occurs downstream of caspase-3 and caspase-9 without Fas receptor-ligand interaction. Exp MoI Med 2001; 33: 284-92.
  • Ohnishi T, Wang X, Ohnishi K, Matsumoto H, Takahashi A. p53-dependent induction of WAFl by heat treatment in human glioblastoma cells. J Biol Chem 1996; 14: 14510-3.
  • Ota I, Ohnishi K, Takahashi A, Yane K, Kanata H, Miyahara H, Ohnishi T, Hasaoi H. Transfection with mutatnt p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2000; 47: 495501.
  • Kastan MB, Onyekwere O, Sidransky P, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 5l: 6304-11.
  • O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutch M, Scudiero DA, Monks A, Saasville FS, Weinstein JN, Friend S, Fomace AJ, Kohn KW. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute Anticancer Drug Screen and correlations with the growth inhibitory potency of 123 anticancer agents. Cancer Res 1997; 57: 4285-300.
  • Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-31.
  • Park HJ, Lyons JC, Griffin RJ, Lim BU, Song CW. Apoptosis and cell cycle progression in an acidic environment after irradiation. Radiat Res 2000; 153: 295-304.
  • Park HJ, Lyons JC, Ohtsubo T, Song CW. The role of p53 in cell cycle progression and apoptosis after irradiation in an acidic environment. Cell Death Differentiation 2000; 7: 729-38.
  • Green DR, Cotter TG. Macromolecular synthesis, c-myc, and apoptosis. In programmed cell death: The cellular and molecular histology of apoptosis. Lavin MI, Walters D, eds. Australia: Harvard Academic Publisher, 1993; 153-66.
  • Kumar S, Lavin MF. The ICE family of cysteine proteases as effectors of cell death. Diff 1996; 3: 255-67.
  • Kojima H, Endo K, Moriyama H, Tanaka Y, Alnemri ES, Slapak CA, Teicher B, Kufe D, Datta R. Abrogation of mitochondria! cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem 1998; 273: 16647-50.
  • Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatininduced apoptosis. J Biol Chem 2000; 275: 39435-43.
  • Granville DJ, Cassidy BA, Ruehlmann DO, Choy JC, Brenner C, Kroemer G, van Breemen C, Margaron P, Hunt DW, McManus BM. Mitochondria! release of apoptosisinducing factor and cytochrome c during smooth muscle cell apoptosis. Am J Pathol 2001; 159:305-11.
  • Hanai A, Yang WL, Ravikumar TS. Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo-injury: mediation by cytochromec release. Int J Cancer 2001; 93: 526-33.
  • Junn E, Mouradian MM. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. / Neurochem 2001; 78: 374-83.
  • Pan J, Xu G, Yeung SC. Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel. J Clin Endocrinol Metab 2001; 86: 4731-40.
  • Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001; 98: 1542-8.
  • Segal MS, Beem E. Effect of pH, ionic charge, and osmolality on cytochromec-mediated caspase-3 activity. Am J Physiol Cell Physiol 2001; 281: Cl 196-204.
  • Rytomaa M, Lehmann K, Downward J. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signaling. Oncogene 2000; 19: 4461-8.
  • Grubb DR, Ly JD, Vaillant F, Johnson K, Lawren A. Mitochondria! cytochrome c release is caspase-dependent and does not involve mitochondria! permeability transition in didemnin B-induced apoptosis. Oncogene 2001; 20: 4085-94.
  • Vantieghem A, Xu Y, Declercq W, Vandenabeele P, Denecker G, Vandenheede JR, Merlevede W, de Witte PA, Agostinis P. Different pathways mediate cytochrome c release after photodynamic therapy with hypericin. Photochem Photobiol 2001; 74: 133-42.
  • Chen Q, Gong B, Almasan A. Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondria! dysfunction in genotoxic stress induced apoptosis. Cell Death Differ 2000; 7: 227-33.
  • Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Distinct pathways for stimulation of cytochrome c release by etoposide. J Biol Chem 2000; 272: 32438-43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.